-
UroLife study clinical data
Data on tumour characteristics, treatment, and recurrence(s), progression and mortality were collected from medical records by data managers of the Netherlands Cancer Registry... -
Tumor mutational landscape in individuals with CMMRD
Whole exome sequencing data from the tumors (n=16) of individuals with constitutional mismatch repair deficiency. Data was aligned to GRCh38. -
300-Obese cohort gut microbiome data
300-Obese cohort was recruited at the Radboud University Medical Center (RUMC), Nijmegen, the Netherlands. The cohort comprises 377 participants included by the following... -
UroLife study general questionnaire
Patients with non-muscle invasive bladder cancer (n=1512) completed paper-and-pencil or web-based questionnaires at 6 weeks (referring to pre-diagnosis lifestyle; n=1486) and 3... -
Whole-exome sequencing of NTHL1 deficient tumors
Whole exome sequencing of 17 tumors from 12 different individuals with biallelic germline NTHL1 mutations from 9 different tissue types. Provided are 17 bam files which are... -
Nederlands RBD Cohort
Data van het Nederlands RBD cohort, inclusief klinische data, neuroimaging, biomaterialen en wearable data. -
PRISMA Questionnaire data
The extensive questionnaire covers a number of potential breast cancer risk predictors such as demographics, personal characteristics, reproductive characteristics, medication,... -
ReLife study quality of life questionnaire
The EORTC QLQ-C30 was completed at 3 (n=365), 12 (n=317) and 24 months (n=279) after surgery. -
POM wearables
Wearable data of the Personalized Parkinson Project, including data obtained with a Verily watch. -
PRIDE Study medication diaries
6-week medication diaries covering prescription and over-the counter use, administered in the second trimester of pregnancy. Available for 1516 PRIDE Study participants... -
PRIDE-BIOME project
Subproject among 116 PRIDE Study participants. Gut microbiome data for maternal samples collected at gestational weeks 20 and 34, and 2 months after the estimated date of... -
PRIDE Study pharmacy data
Details on prescription medication fills in the three months before the last menstrual period until 6 months after the estimated date of delivery. Necessitates additional... -
POM imaging data
Imaging data of the Personalized Parkinson Project, including structural and functional MRI. -
ProPark
Data van het ProPark cohort, inclusief klinische data, neuroimaging, biomaterialen en wearable data. -
POM clinical data
Clinical data of the Personalized Parkinson Project, including motor scores, cognitive and neuropsychiatric assessments, autonomic symptoms, sleep and quality of life. -
ReLife study tissue samples
Permission is available for collection of tumour blocks. -
UroLife study molecular subtypes
Molecular subtype based on immunohistrochemistry performed on tissue microarrays is available for 389 T1 NMIBC tumours. -
PRIDE Study nutrition
Food frequency questionnaire administered in early pregnancy, assessing multiple macronutrients and micronutrients. -
ReLife study quality of life questionnaire
The EORTC QLQ-C30 was completed at 3 (n=365), 12 (n=317) and 24 months (n=279) after surgery. -
PRIDE Study pharmacy data
Details on prescription medication fills in the three months before the last menstrual period until 6 months after the estimated date of delivery. Necessitates additional...
U kunt ook het register raadplegen met behulp van de API (see API documentatie).